Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?

BACKGROUND: Patients hospitalized with COVID-19 experienced an increased risk of venous thromboembolism. AIMS: To evaluate the effect of chronic oral anticoagulation (OAC) therapy, both with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), on prognosis of COVID-19 older patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Covino, Marcello, De Matteis, Giuseppe, Della Polla, Davide, Burzo, Maria Livia, Pascale, Marco Maria, Santoro, Michele, De Cristofaro, Raimondo, Gasbarrini, Antonio, De Candia, Erica, Franceschi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254066/
https://www.ncbi.nlm.nih.gov/pubmed/34216379
http://dx.doi.org/10.1007/s40520-021-01924-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254066/
https://www.ncbi.nlm.nih.gov/pubmed/34216379
http://dx.doi.org/10.1007/s40520-021-01924-w

Ejemplares similares